Publication
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection FractionClinical Perspective
A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
Inder S. Anand, Michel Komajda, John S. Gottdiener, Peter E. Carson, John J. V. McMurray, Søren L. Kristensen, Ulrik M. Mogensen, Pardeep S. Jhund, Mark C. Petrie, David Preiss, Sithu Win, Lars Køber, Robert S. McKelvie, Michael R. Zile
Circulation, January 2017, Wolters Kluwer Health
DOI: 10.1161/circulationaha.116.024593